Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biocorrx Inc (BICX)

Biocorrx Inc (BICX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 17,320
  • Shares Outstanding, K 7,069
  • Annual Sales, $ 50 K
  • Annual Income, $ -5,210 K
  • 60-Month Beta 0.93
  • Price/Sales 368.20
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BICX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.70
  • Most Recent Earnings -0.14 on 05/16/22
  • Next Earnings Date 08/15/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.2200 +10.36%
on 06/15/22
2.5000 -2.00%
on 06/30/22
-0.0500 (-2.00%)
since 06/01/22
3-Month
2.2100 +10.86%
on 05/05/22
3.4800 -29.60%
on 04/11/22
-0.9800 (-28.57%)
since 04/01/22
52-Week
2.2100 +10.86%
on 05/05/22
7.5000 -67.33%
on 11/10/21
-1.8600 (-43.16%)
since 07/01/21

Most Recent Stories

More News
BioCorRx Featured on LiveNOW from FOX

ANAHEIM, CA, June 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 2.4500 (-2.00%)
BioCorRx to Present at the LD Micro Invitational XII on June 7th

ANAHEIM, CA, May 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 2.4500 (-2.00%)
BioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse Setting

Collaboration to create a synergistic treatment offering, combining BioCorRx’s MAT treatment program and 2B3D virtual reality technology Plans toward...

BICX : 2.4500 (-2.00%)
BioCorRx Business Update for the First Quarter of 2022

ANAHEIM, CA, May 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire  – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 2.4500 (-2.00%)
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV

LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at Bally's...

CHL.AX : 1.710 (unch)
DCM : 25.60 (-1.35%)
DDDX : 0.0490 (+6.52%)
AAT.VN : 0.050 (+11.11%)
AATGF : 0.0310 (-17.99%)
ASTR.VN : 0.185 (+2.78%)
AMI.VN : 0.300 (+3.45%)
AUUD : 0.8855 (+1.28%)
AYRO : 0.8450 (+0.85%)
BNXA.VN : 1.260 (-1.56%)
BNXAF : 0.9375 (+1.84%)
BICX : 2.4500 (-2.00%)
BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

ANAHEIM, CA, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 2.4500 (-2.00%)
BioCorRx to Present at the Planet MicroCap Showcase 2022 in Las Vegas on May 4th

ANAHEIM, CA / ACCESSWIRE / April 26, 2022 / BioCorRx Inc. (OTCQB:BICX) (the "Company"), a developer and provider of innovative treatment programs fr substance abuse and related disorders, today announced...

BICX : 2.4500 (-2.00%)
BioCorRx Announces Additional Award of Nearly $100,000 from NIDA for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

ANAHEIM, CA, April 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 2.4500 (-2.00%)
BioCorRx Provides 2021 Year-End Business Update

ANAHEIM, CA, April 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 2.4500 (-2.00%)
BioCorRx to Participate in Two Upcoming Conferences

ANAHEIM, CA, March 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 2.4500 (-2.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 2.4767
2nd Resistance Point 2.4633
1st Resistance Point 2.4567
Last Price 2.4500
1st Support Level 2.4367
2nd Support Level 2.4233
3rd Support Level 2.4167

See More

52-Week High 7.5000
Fibonacci 61.8% 5.4792
Fibonacci 50% 4.8550
Fibonacci 38.2% 4.2308
Last Price 2.4500
52-Week Low 2.2100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar